Back to top
more

Ingevity (NGVT)

(Delayed Data from NYSE)

$42.00 USD

42.00
400,023

+0.21 (0.50%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $42.00 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (142 out of 250)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ingevity's Earnings Beat Estimates in Q3, Revenues Down Y/Y

by Zacks Equity Research

The downside in NGVT's Q3 sales is attributable to the repositioning of the Performance Chemicals segment.

Ingevity (NGVT) Soars 12.0%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Ingevity (NGVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Ingevity to Launch Capa HS at the 2024 Polyurethanes Conference

by Zacks Equity Research

The Capa HS series is the latest example of NGVT's current innovation push, which is extending the performance boundaries of Caprolactone technology.

Why Is Ingevity (NGVT) Down 7.4% Since Last Earnings Report?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Flexible Solutions (FSI) Q2 Earnings & Sales Top Estimates

by Zacks Equity Research

Flexible Solutions' (FSI) Biodegradable Polymers sales rise in Q2 on higher customer orders.

American Vanguard (AVD) Q2 Earnings and Sales Miss Estimates

by Zacks Equity Research

Unfavorable market conditions weigh on American Vanguard's (AVD) top line in the second quarter.

Koppers (KOP) Earnings Surpass Estimates, Sales Lag in Q2

by Zacks Equity Research

Koppers (KOP) sees record sales in its Railroad and Utility Products and Services segment on higher pricing and increased crosstie and utility poles volumes in Q2.

Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q2

by Zacks Equity Research

Ingevity's (NGVT) top line declines in Q2 due to the Performance Chemicals segment's repositioning, which included limiting exposure to specific markets within the Industrial Specialties product line.

Ingevity (NGVT) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of -3.81% and 5.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales

by Zacks Equity Research

The addition of a new distribution partner in Europe devoted to Ingevity's (NGVT) Capa biodegradable thermoplastics allows the company to better service its customers in the region.

Ingevity (NGVT) Down 12.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hawkins (HWKN) Earnings Lag Estimates in Q4, Revenues Beat

by Zacks Equity Research

Hawkins (HWKN) sees strong growth in the Water Treatment segment in the fiscal fourth quarter.

American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates

by Zacks Equity Research

American Vanguard's (AVD) U.S. crop business registers strong sales of granular soil insecticides, herbicides and cotton and peanut products in Q1.

Innospec's (IOSP) Q1 Earnings Surpass Estimates, Sales Lag

by Zacks Equity Research

Strong results in the Performance Chemicals segment drove Innospec's (IOSP) earnings in Q1.

Valvoline's (VVV) Earnings and Revenues Beat Estimates in Q2

by Zacks Equity Research

Valvoline's (VVV) fiscal second-quarter earnings and revenues surpass estimates on higher system-wide same-store sales.

Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.

Linde's (LIN) Q1 Earnings Beat Estimates on Higher Pricing

by Zacks Equity Research

Higher pricing from the Americas segment aids Linde's (LIN) Q1 earnings, offset partially by lower contributions from the Engineering business unit.

Ingevity (NGVT) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Ingevity (NGVT) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 40.54% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Wil Higher Uranium Prices Aid Energy Fuels' (UUUU) Q1 Earnings?

by Zacks Equity Research

Energy Fuels' (UUUU) first-quarter 2024 results are likely to reflect increased uranium sales, as the company is expected to have capitalized on the elevated prices witnessed throughout the quarter.

Olin's (OLN) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

Olin's (OLN) first-quarter earnings and sales surpass the respective estimates as strong Winchester results offset the weakness in its Chemical businesses.

Air Products (APD) Earnings Beat, Revenues Miss Estimates in Q2

by Zacks Equity Research

Air Products' (APD) fiscal second-quarter earnings surpass estimates while sales miss the same due to lower volumes.

Albemarle (ALB) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost and productivity actions in the first quarter amid headwinds from softer lithium market prices.

Will Lower Production Weigh on Barrick's (GOLD) Q1 Earnings?

by Zacks Equity Research

Lower gold production and higher costs are likely to have affected Barrick's (GOLD) Q1 performance.

WestRock (WRK) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

WestRock's (WRK) Q2 results are likely to reflect lower volumes due to muted customer spending.